Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ex Vivo Normothermic Perfusion in Kidney Transplantation.

NCT: NCT05175885 · RECRUITING

NCT IDNCT05175885
StatusRECRUITING
Start Date2023-12-14
Completion2029-12
SponsorEbers Medical Technology, S.L. (INDUSTRY)
First posted
Last updated

Brief Summary

A multicenter, prospective and open-label clinical investigation to evaluate the viability, performance and safety of ex vivo normothermic perfusion in kidney transplantation from DCD and DBD donors.

Frequently Asked Questions

What is Ex Vivo Normothermic Perfusion in Kidney Transplantation.?

Ex Vivo Normothermic Perfusion in Kidney Transplantation. is a clinical trial registered under NCT05175885. Current status: RECRUITING.

What is the status of NCT05175885?

The current status of NCT05175885 (Ex Vivo Normothermic Perfusion in Kidney Transplantation.) is: RECRUITING.

When did Ex Vivo Normothermic Perfusion in Kidney Transplantation. start?

Ex Vivo Normothermic Perfusion in Kidney Transplantation. started on 2023-12-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.